Legend Biotech Corporation
LEGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39 | -$125 | -$99 | $41 |
| Dep. & Amort. | $6 | $6 | $5 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $15 | $19 | $16 | $13 |
| Change in WC | $77 | -$37 | -$74 | -$80 |
| Other Non-Cash | -$30 | $124 | $48 | -$63 |
| Operating Cash Flow | $29 | -$13 | -$104 | -$82 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$9 | -$2 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$387 | -$4,050 | -$100 | -$313 |
| Inv. Sales/Matur. | $381 | $3,900 | $374 | $233 |
| Other Inv. Act. | -$9 | -$6 | -$15 | -$5 |
| Investing Cash Flow | -$20 | -$166 | $257 | -$88 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$1 | -$1 | -$1 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $1 | $1 |
| Financing Cash Flow | $1 | -$1 | $1 | -$0 |
| Forex Effect | $3 | $4 | $1 | -$2 |
| Net Chg. in Cash | $12 | -$175 | $155 | -$173 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $267 | $442 | $287 | $459 |
| End Cash | $279 | $267 | $442 | $287 |
| Free Cash Flow | $24 | -$22 | -$106 | -$84 |